Project Description

CEO: Jurgi Camblong

Sector: Genomics
Location: Saint-Sulpice, Switzerland and Boston Massachusetts, US
Investment Stage: Growth
Investment Status: Current
Year Invested: 2020


SOPHiA GENETICS’ AI-based platform helps healthcare professionals make sense of genomic and radiomic data while sharing their knowledge through the world’s largest network of institutions, supporting them in their decision-making to improve diagnosis and treatment of cancer and rare diseases. SOPHiA GENETICS’ solutions are democratising data-driven medicine, bringing precision medicine and targeted therapies to more patients in 85 countries.

The company completed its initial public offering in July, 2021, and is registered under the ticker Nasdaq:SOPH.

See SOPHiA GENETICS related news here

Back to all companies

Endeavour Vision
Deal Team

Damien Tappy
Fernando Pacheco